Nasdaq orders Nuvve Holding Corp. delisted, trading to halt July 24
SAN DIEGO, July 23. Trading in Nuvve Holding Corp. common stock will halt at the open of markets July 24, 2026, after the Nasdaq Hearings Panel determined to delist the shares for failure to satisfy three continued listing rules, according to an 8-K the company filed with the Securities and Exchange Commission. The company, based in San Diego, California, trades under the ticker NVVE on The Nasdaq Capital Market.
Key takeaways
- The Nasdaq Hearings Panel determined to delist Nuvve Holding Corp. (ticker NVVE) for failing to satisfy three continued listing rules, per an 8-K filed with the SEC.
- Trading in Nuvve common stock on The Nasdaq Capital Market will halt at the open of markets on July 24, 2026.
- Nasdaq cited non-compliance with the periodic reporting rule, the $1.00 minimum bid price requirement, and the $2,500,000 stockholders' equity threshold.
- Nuvve expects its common stock to begin trading on the Pink Limited Information Tier of OTC Markets under the symbol NVVE on July 24, 2026, and intends to apply for the OTCID and then OTCQB tiers.
- Under Nasdaq Listing Rule 5820, Nuvve has 15 days from July 22, 2026, to appeal the Panel's determination to the Nasdaq Listing and Hearing Review Council.
SAN DIEGO, July 23. Trading in Nuvve Holding Corp. common stock will halt at the open of markets July 24, 2026, after the Nasdaq Hearings Panel determined to delist the shares for failure to satisfy three continued listing rules, according to an 8-K the company filed with the Securities and Exchange Commission. The company, based in San Diego, California, trades under the ticker NVVE on The Nasdaq Capital Market.
Three listing failures
Nasdaq cited non-compliance with the periodic reporting rule, the $1.00 minimum bid price requirement, and the $2,500,000 stockholders' equity threshold. The Panel had set July 13, 2026, as the deadline for Nuvve to file its quarterly report for the period ended March 31, 2026, and to demonstrate equity compliance. Bid price compliance, defined as 20 consecutive business days above $1.00, was required by July 31, 2026.
The delisting determination reached Nuvve on July 22, 2026. The timeline moved in stages before that. Nasdaq's Listing Qualifications Department notified the company of continued non-compliance with the bid price rule on April 20, 2026, prompting Nuvve to request a hearing. A second notice, dated May 22, 2026, identified the periodic reporting failure as an additional basis for delisting. The Panel heard the company's compliance plan, including its position on the equity rule, at a hearing May 28, 2026, and issued its decision July 9, 2026.
Appeal options and OTC transition
Under Nasdaq Listing Rule 5820, Nuvve has 15 days from July 22, 2026, to appeal the Panel's determination to the Nasdaq Listing and Hearing Review Council. The Listing Council may also separately elect to review the matter within 45 days. If the company does not appeal and the Listing Council declines to intervene, Nasdaq will file a Form 25 with the SEC to formally effect the delisting once all review periods lapse.
The company said it is considering all available options to reinitiate trading on Nasdaq. Nuvve said it expects its common stock to begin trading on the Pink Limited Information Tier of the OTC Markets system under the symbol NVVE on July 24, 2026, and intends to apply for the OTCID tier and subsequently the OTCQB tier. The 8-K was signed by Gregory Poilasne, chief executive officer, and dated July 23, 2026.